Enfortumab Vedotin

Basic Information

Item Value
DrugBank ID DB13007
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 100

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 leprosy KG + DL
2 multiple endocrine neoplasia KG + DL
3 cytomegalovirus infection KG + DL
4 candidiasis KG + DL
5 cerebral infarction KG + DL
6 HIV infectious disease KG + DL
7 homozygous familial hypercholesterolemia KG + DL
8 malignant catarrh KG + DL
9 infectious bovine rhinotracheitis KG + DL
10 HER2 positive breast carcinoma KG + DL
11 simian immunodeficiency virus infection KG + DL
12 feline acquired immunodeficiency syndrome KG + DL
13 Prinzmetal angina KG + DL
14 oral candidiasis KG + DL
15 cerebral arterial disease KG + DL
16 coronary artery disease KG + DL
17 neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter KG + DL
18 breast fibrocystic disease KG + DL
19 commissural lip fistula KG + DL
20 osteoradionecrosis of the mandible KG + DL
21 burning mouth syndrome KG + DL
22 oral leukoedema KG + DL
23 anomalous left coronary artery from the pulmonary artery KG + DL
24 myocardial ischemia KG + DL
25 female breast carcinoma KG + DL
26 stroke disorder KG + DL
27 progesterone-receptor negative breast cancer KG + DL
28 normal breast-like subtype of breast carcinoma KG + DL
29 progesterone-receptor positive breast cancer KG + DL
30 breast tumor luminal A or B KG + DL
31 fibroma of prostate KG + DL
32 benign reproductive system neoplasm KG + DL
33 benign mammary dysplasia KG + DL
34 Brenner tumor KG + DL
35 adrenal gland hyperfunction KG + DL
36 thrombocytopenia KG + DL
37 benign prostate phyllodes tumor KG + DL
38 obsolete familial combined hyperlipidemia KG + DL
39 amenorrhea (disease) KG + DL
40 acne (disease) KG + DL
41 male reproductive organ cancer KG + DL
42 roseolovirus infectious disease KG + DL
43 breast abscess KG + DL
44 fat necrosis of breast KG + DL
45 hypoalphalipoproteinemia KG + DL
46 hereditary thrombocytopenia with normal platelets KG + DL
47 prostate leiomyoma KG + DL
48 marcothrombocytopenia with mitral valve insufficiency KG + DL
49 pulmonary hypertension KG + DL
50 lactation disease KG + DL

(Showing top 50 of 100 predictions)

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). For research purposes only. Not medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.